BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12182962)

  • 1. Study of cannabinoid dependence in animals.
    Maldonado R
    Pharmacol Ther; 2002 Aug; 95(2):153-64. PubMed ID: 12182962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptors and reward in the rat: a conditioned place preference study.
    Cheer JF; Kendall DA; Marsden CA
    Psychopharmacology (Berl); 2000 Jul; 151(1):25-30. PubMed ID: 10958113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
    Panagis G; Vlachou S; Nomikos GG
    Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabinoid dependence in animal models].
    Biała G
    Postepy Hig Med Dosw (Online); 2008 May; 62():258-62. PubMed ID: 18542046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.
    Tanda G
    Psychopharmacology (Berl); 2016 May; 233(10):1845-66. PubMed ID: 27026633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys.
    Winsauer PJ; Lambert P; Moerschbaecher JM
    Behav Pharmacol; 1999 Sep; 10(5):497-511. PubMed ID: 10780256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new synthetic cannabinoids: lessons from animal models.
    Zanda MT; Fattore L
    Drug Metab Rev; 2018 Feb; 50(1):54-64. PubMed ID: 29376443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
    Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
    Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid-Induced Conditioned Place Preference, Intravenous Self-Administration, and Behavioral Stimulation Influenced by Ghrelin Receptor Antagonism in Rats.
    Charalambous C; Havlickova T; Lapka M; Puskina N; Šlamberová R; Kuchar M; Sustkova-Fiserova M
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
    Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
    J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.
    Lefever TW; Marusich JA; Antonazzo KR; Wiley JL
    Pharmacol Biochem Behav; 2014 Mar; 118():30-5. PubMed ID: 24412835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
    Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cannabinoid receptor in the brain as it relates to drug reward.
    Yamamoto T; Takada K
    Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-administration of cannabinoids by experimental animals and human marijuana smokers.
    Justinova Z; Goldberg SR; Heishman SJ; Tanda G
    Pharmacol Biochem Behav; 2005 Jun; 81(2):285-99. PubMed ID: 15932767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.